Nu Skin Enterprises Inc(NUS) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Full metrics table
| Index | RUT | P/E | - | EPS (ttm) | -4.47 | Insider Own | 2.95% | Shs Outstand | 48.7M | Perf Week | 1.04% |
| Market Cap | 0.24B | Forward P/E | 4.21 | EPS next Y | 41.46% | Insider Trans | -1.18% | Shs Float | 47.2M | Perf Month | 0.21% |
| Enterprise Value | 0.31B | PEG | - | EPS next Q | 0.21 | Inst Own | 75.15% | Short Float | 9.4% | Perf Quarter | -10.13% |
| Income | -0.22B | P/S | 0.17 | EPS this Y | -35.43% | Inst Trans | -0.09% | Short Ratio | 6.67 | Perf Half Y | -33.24% |
| Sales | 1.38B | P/B | 0.44 | EPS next 5Y | - | ROA | -16.87% | Short Interest | 4.44M | Perf YTD | -49.27% |
| Book/sh | 11.14 | P/C | 1.24 | EPS past 3/5Y | 15.37% -2.56% | ROE | -32.53% | 52W High | -66.62% ($14.62) | Perf Year | -57.64% |
| Cash/sh | 3.93 | P/FCF | 22.04 | Sales past 3/5Y | -12.61% -10.47% | ROIC | -27.51% | 52W Low | 8.69% ($4.49) | Perf 3Y | -78.97% |
| Dividend Est. | $0.24 (4.92%) | EV/EBITDA | 2.58 | EPS Y/Y TTM | -319.79% | Gross Margin | 69.19% | Volatility(W/M) | 5.17% 4.55% | Perf 5Y | -89.7% |
| Dividend TTM | 0.24 | EV/Sales | 0.23 | Sales Y/Y TTM | -15.44% | Oper. Margin | 5.11% | ATR (14) | 0.21 | Perf 10Y | -91.65% |
| Dividend Ex-Date | 2026/8/28 | Quick Ratio | 1.24 | EPS Q/Q | -1304.66% | Profit Margin | -15.73% | RSI (14) | 50.21 | Recom | 3 |
| Dividend Gr. 3/5Y | -46.19% -30.69% | Current Ratio | 1.98 | Sales Q/Q | -17.1% | SMA20 | 2.28% ($4.77) | Beta | 0.89 | Target Price | $12.77 |
| Payout | 7.54% | Debt/Eq | 0.49 | Earnings | 2026/8/10 | SMA50 | -2.67% ($5.01) | Rel Volume | 0.76 | Prev Close | $4.85 |
| Employees | 8600 | LT Debt/Eq | 0.45 | EPS/Sales Surpr. | - -7.27% | SMA200 | -33.67% ($7.36) | Avg Volume(3M) | 0.67M | Price | $4.88 |
| IPO | 1996/11/22 | Option/Short | Yes/Yes | Trades | 3504 | Volume | 504,840 | Change | 0.62% |
Company
NUS is a Consumer Defensive sector company, analyzed across 14 metrics on this page including P/E, EPS, dividends, RSI, and MACD.
💄 Nu Skin Enterprises (NUS) is a US-based household products and personal care company that supplies beauty and wellness products to global markets through direct selling. The company operates a differentiated product line centered on its ageLOC brand, combining skincare devices with nutritional supplements.
Over the past 1 year, on the lower side
67% below its 1-year high.
NUS has weak earning power
Losses or thin margins. Early-stage growth or weakening competitiveness
Tap to view numbers
Growth is moderate
Earnings are expected to grow by -35.4% this year.
Tap to view numbers
The price looks about right
Trading at - times earnings.
Tap to view numbers
Results have missed expectations
Frequently misses analyst estimates
Tap to view numbers
The outlook is positive
Analyst sentiment is Hold.
Tap to view numbers
Holding long would have lost money
Would have changed by -79.0% if bought 5 years ago.
Tap to view numbers
Dividends are paid consistently
Pays 4.92% annually in dividends.
Tap to view numbers
Ownership looks stable
Institutions hold 75.2%.
Tap to view numbers
Multiple ETFs hold this stock
Buying this ETF gives you exposure to this stock as well.
It ranks #4 in the industry
Based on market cap of $238M.
FAQ
What kind of company is NUS?
NUS belongs to the Consumer Defensive sector and operates in the Household & Personal Products industry.
What is the market cap of NUS?
The market cap of NUS is approximately $238M, ranking 3,958 within its sector.
Does NUS pay dividends?
NUS has a dividend yield of approximately 4.92%, with an annual dividend of $0.24.
What is the 52-week high and low for NUS?
NUS has recorded a 52-week high of $14.62 and a low of $4.49.